BWXT stock forecast, quote, news & analysis

Key Takeaways

• BWXT reported record 2025 revenue of $3.2 billion, up 18% year-over-year, with non-GAAP EPS of $4.01.
• Backlog expanded 50% to $7.3 billion, fueled by naval propulsion, special materials, and commercial nuclear awards.
• 2026 guidance includes non-GAAP EPS of $4.55–$4.70 and revenue around $3.75 billion, exceeding consensus estimates.
• Recent Q4 earnings beat drove initial share gains, though valuation concerns tempered some upside.
• Analyst consensus remains "Buy" with an average price target of $231, supported by nuclear demand tailwinds.
• Strategic hires and facility expansions position BWXT for defense and commercial nuclear growth.

Current Market Snapshot

BWXT shares have shown resilience in recent trading sessions amid heightened interest in nuclear energy and defense spending. The stock has advanced significantly over the past year, reflecting strong fundamentals in naval nuclear components and emerging commercial opportunities. Trading above key moving averages, BWXT benefits from a robust backlog providing revenue visibility, though elevated valuations prompt caution among some observers. Broader sector momentum in advanced manufacturing and clean energy supports the stock's position, with investor sentiment buoyed by consistent execution on high-margin contracts.

Trending AI Robots

Tickeron’s Trending AI Robots page showcases a curated selection of over 25 high-performing AI trading bots from its extensive library of hundreds of bots that analyze and trade thousands of tickers across stocks, ETFs, and crypto. These bots employ diverse strategies—ranging from short-term momentum plays on 5-minute charts to swing trades on hourly timeframes—tailored to current market volatility and sector rotations. Top performers display impressive stats, such as annualized returns up to +254%, win rates of 70-95%, and profit factors exceeding 3.0, often outperforming the S&P 500 in sectors like aerospace & defense, semiconductors, and infrastructure. For instance, aerospace-focused bots have delivered +123% annualized returns with 75% win rates, while volatility agents show profit-to-drawdown ratios over 10. This dynamic leaderboard highlights bots best suited to prevailing conditions, enabling users to follow proven performers with built-in risk management. Explore the Trending AI Robots for potential edges in navigating stocks like BWXT.

Recent Developments Driving BWXT Price Action

BWX Technologies, a leading supplier of nuclear components for U.S. naval propulsion and commercial power, has experienced volatile but upward price action in recent weeks, driven by stellar Q4 and full-year 2025 results announced on February 23, 2026. The company posted Q4 revenue of $885.8 million, up nearly 19% year-over-year, and non-GAAP EPS of $1.08, surpassing consensus estimates of $0.89 EPS and $837.5 million in sales. Full-year revenue reached a record $3.2 billion (18% growth), with adjusted EBITDA of $574.3 million and free cash flow of $295.3 million. These figures beat internal expectations, prompting an initial 5% share surge as investors digested the strength in government operations (naval nuclear components up) and commercial segments (field services, fuel, and medical isotopes).

Central to the momentum was a 50% backlog expansion to $7.3 billion, powered by multi-year awards in naval propulsion equipment, high-purity depleted uranium ($1.6 billion contract), U.S. defense uranium enrichment, CANDU reactor life extensions, small modular reactors (SMRs), and an AP1000 engineering role in Bulgaria. Acquisitions of AOT and Kinectrics earlier in 2025 bolstered capabilities, enabling these wins and diversifying revenue beyond core naval work (over 80% of sales).

Management initiated 2026 guidance ahead of Street forecasts: revenue ~$3.75 billion (vs. $3.67 billion consensus), non-GAAP EPS $4.55–$4.70 (midpoint $4.63 vs. $4.30), adjusted EBITDA $645–$660 million, and free cash flow $305–$320 million. This outlook, tied to backlog conversion and commercial ramp-up, fueled optimism but also profit-taking, with shares pulling back from early post-earnings highs amid valuation debates (trading at premiums to peers).

Other catalysts included a quarterly dividend hike to $0.27 (8% increase, ex-date March 11), signaling cash flow confidence, and executive appointments: Dan Jablonsky (aerospace veteran) to the board on February 20 and Kurt Bender as Chief Digital Officer on February 5. These moves enhance strategic depth in defense and digital transformation. Analyst reactions were positive, with BTIG raising its target to $235 (Buy) on February 26, citing nuclear tailwinds, though Seaport's January downgrade to Neutral flagged valuations. Jim Cramer's recent nod as a top defense/nuclear play added retail buzz. Macro factors like rising U.S. defense budgets and nuclear renaissance (SMRs, data centers) amplified sentiment, though contract timing risks capped gains.

2026 Outlook and Key Factors to Monitor

As BWXT enters 2026 with a $7.3 billion backlog, focus shifts to execution on naval nuclear programs, uranium enrichment expansion, and commercial nuclear scaling. Revenue growth to ~$3.75 billion hinges on converting awards in SMRs, AP1000 projects, CANDU extensions, and medical isotopes, amid industry trends like U.S. nuclear capacity quadrupling to 400 GW by 2050 and data center power demands. Government operations (naval reactors for Virginia/Columbia-class subs) offer stability via sole-supplier status, while commercial ops target margin expansion through acquisitions' integration.

Opportunities include DOE contracts, TRISO fuel production, microreactors (Project Pele delivery 2027), and international nuclear revival. Risks encompass program ramp-up delays, supply chain pressures, margin squeezes in fixed-price deals, and policy shifts in defense budgets or energy subsidies. Facility expansions (e.g., Innovation Campus, Cambridge plant) and capex (~$185 million in 2025) support capacity but demand cost discipline. Competitive positioning in high-barrier nuclear tech remains strong, with balanced monitoring of backlog bookings, EBITDA margins, and free cash flow conversion essential.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.